IFNG and neoplasm: The IFNG-rs1861494 polymorphism was successfully integrated in a previously published clinical-genetic score including other clinical risk factors (i.e., gender, primary tumor site, and tumor stage) and the patient’s genotype for MTHFR-rs1801131.